PUBLISHED DATE : Feb 2023 | Pages : 310
Fill out your details & get your free sample
The Lateral Flow Assays Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
310 Pages
146 Tables
141 Charts
5 Regions
20 Countries
37 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 11.30 Billion |
| Market Size (2022) | USD 9.53 Billion |
| CAGR (2022-2028) | 2.89% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Product, Application, Technique, End-Users, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Abbott, F. Hoffmann-La Roche, Danaher, Siemens Healthineers, and Danaher |
The global lateral flow assays market was valued at USD 9.53 billion in 2022 and is expected to reach USD 11.30 billion by 2028, growing at a CAGR of 2.89%. The market is one of the major segments in the global point of care or the rapid diagnostics market and is growing steadily and is anticipated to grow at a similar pace during the forecast period. Further, the growth in the market is attributed to the increasing prevalence/incidence of various infectious and chronic diseases. In addition, malaria is still a cause of death in a few regions. For instance, according to the WHO, malaria is one of the leading causes of death in the Middle East & Africa.
Moreover, the general population, especially the elderly and children, require periodic health checkups for seasonal flu during monsoon and winter, collectively fueling the rapid diagnostics market. In addition, the Covid-19 pandemic has positively impacted the market with a surge in demand for rapid Covid-19 tests. Various countries like the UK, Germany, France, Russia, USA are planning to perform mass testing to screen their country population and take necessary steps to prevent the spread of the disease. Such factors have increased the demand for rapid test kits globally. Rapid testing plays a significant role in monitoring the pandemic situation. Furthermore, increased use of diagnostics tests for various purposes, such as routine health checkups, infectious diseases, seasonal flu, blood donation, blood preservations, and blood transfusion, boosts the lateral flow assays market.
Smartphone and AI Integration in Lateral Flow Immunoassay
The use of smartphones as biosensors in many applications (e.g., optical-based methods such as absorption, reflection, fluorescence, etc.) is particularly important for improving diagnostics, healthcare, medical, food, and environmental monitoring. It has the potential as a portable, low-cost POC platform and provides treatment in remote low-income areas. The Cambridge-based startup, PocDoc, has received CE mark approval for a digital reader powered with artificial intelligence (AI) for lateral flow testing. The cloud-based system turns any smartphone or tablet into a universal digital reader, enabling healthcare organizations to perform large-scale lateral flow testing for any disease or marker. An AI-driven innovation that can read a COVID-19 lateral flow diagnostic test using a user's smartphone has received special use approval from the Medicines and Healthcare Products Regulatory Agency (MHRA).
Evolving New Application of Lateral Flow Assays
Lateral flow testing is widely used for infectious disease diagnosis, heart disease diagnosis, and veterinary applications but has seen increased use in recent years in several new applications. For example, saliva diagnostics, behavioral health, agriculture (detection of genetically modified organisms and quality control of plants), biological warfare (detection of Bacillus anthracis), environmental testing (detection of contaminating enzymes in production facilities), food microbiology (E. coli Detection of O157, Salmonella, Listeria, and other food spoilage bacteria) has emerged as a new application area in the lateral flow assays market.
Saliva is a new biological fluid with many studies and clinical applications. OraSure Technologies, based in the US, is one of the largest lateral flow saliva testing vendors. Salivary LFAs have also infiltrated the market for applications such as substance abuse testing, and several systems have been cleared for sale by the FDA. However, the tests remain largely qualitative.
Growing Adoption of Home-Based Lateral Flow Assay Devices
Home tests (also called self-tests or home tests) are typically sold over the counter and allow users to test self-collected samples and obtain results without the assistance of a trained medical professional. The home-use lateral flow assay device plays an important role in the treatment of cardiovascular disease and infectious diseases. These devices could also be very useful for testing pregnancy and stigmatized diseases such as HIV, allowing patients to perform self-tests at home. Therefore, the increasing incidence of these diseases and the growing adoption of lateral flow assay testing in home healthcare are expected to propel the lateral flow assays market growth. During COVID-19, many companies have introduced at-home lateral flow assays for COVID-19 testing. This is because people feared rushing to a diagnostic lab or hospital for testing has created a demand for at-home lateral flow assays. Some of the introduced tests for home use were:
INSIGHTS BY PRODUCT
The kits & reagents are expected to be the largest product segment in the global lateral flow assays market in 2022, accounting for a share of 82.24%. These kits & reagents predominantly include biomarkers, assay kits, and reagents, including substrates, enzymes, specific proteins, lipids, and other test kits. The awareness of rapid and POC testing for various infectious diseases is one of the key factors driving the demand for rapid testing. The large market share of the segment is also attributed to the use of consumables reoccurring in nature, and the consumables segment generates continuous revenue for vendors. As a result, many renowned vendors are manufacturing consumables required for analyzers. This growth is attributable to the growing use of rapid tests in several points of care (POC) sites, such as emergency care, physician offices, ambulatory settings, nursing homes, and by individuals for diagnosing several diseases such as infectious diseases, diabetes, cancer, and other metabolic diseases.
INSIGHTS BY APPLICATION
The global lateral flow assays market is segmented into clinical diagnostics, food safety, veterinary diagnostics, and others. Clinical application accounted for the global market's highest share, 46.50%, in 2022. Rapid infectious disease diagnostic tests are critical for diagnosing diseases for early detection and biosurveillance and improving global health. For instance, the Health and Human Services (HHS), the National Institutes of Health (NIH), the US Centers for Disease Control and Prevention (CDC), and the US Department of Defense (DoD) consider rapid and early detection a keyway to reduce the impact on the population. The POC provides multiple advantages over other diagnostics to diagnose infectious diseases, especially for rapid testing scenarios. For instance, Chembio, a leading lateral flow assay market company, is offering FDA-approved LFA HIV tests, SURE CHECK HIV 1/2 Assay, which combines a patented plastic "barrel" device that houses the lateral flow strip.
The global lateral flow assays market by food safety is expected to reach USD 3.83 billion by 2028. The lateral flow test is a very convenient immunoassay for detecting foodborne pathogens. The test covers the most important pathogens, acts as a minilab, and includes built-in control reactions for optimized pathogen testing. There are many leading and local players offering LFA testing for food testing, including Sigma-Aldrich, a subsidiary of Merck kGaA, Perkinelmer, R- Biopharma, Abingdon Health, and creative diagnostics.
INSIGHTS BY TECHNIQUE
The sandwich assays held the most significant technique segment share in the global lateral flow assays market in 2022 at 61.36%. The first type of LFA assay is a non-competitive or sandwich assay. It is used for macromolecular analytes with two antigen-binding sites: which bind to the target and has a binder that does not interfere with each other. If the target is present in the sample, the signal at the test line will increase. The LFA vendor uses the sandwich technique to market their product; the best-known examples of this format are the over-the-counter pregnancy tests. The sandwich assays account for a larger share of the technique segment, also growing with a high growth rate of 3.39% in the market. At the same time, the competitive segment accounted for 38.64% of the global lateral flow assays market.
INSIGHTS BY END USERS
The global lateral flow assays market is segmented into hospitals & clinics, individuals, diagnostic laboratories, food & beverage companies (FBC), pharma & biotech companies (PBC), and others by end-users. The hospitals & clinics held the largest end-users market share at 25.32% in 2022. Hospitals perform more rapid tests than other end-users and form the first point of contact for infections and diseases. The diagnosis is used for the initial patient screening, thereby contributing to the larger use of rapid testing in hospitals. Moreover, hospitals establish contracts with multiple vendors for procuring rapid test kits, POC analyzers, and related consumables. In addition, hospital laboratories are unique entities in hospitals. Around 92% of the hospitals operate with their laboratories. Hospitals are one of the largest end-users of infectious disease diagnosis, which perform a wide range of diagnostics per the requirement.
The global lateral flow assays market by individuals was valued at USD 1.87 billion in 2022. Initially, home care settings were introduced to reduce hospital resource utilization for longer periods. This became popular, and the demand for home care has gone high. The demand is extremely high in developed countries. The aged population is increasing globally, and usage of blood glucose monitoring and other tests is increasing across the home care segment. With the usage of rapid testing, there are multiple advantages to home health care providers. This provides rapid turnaround times, improved decision times, and time-critical decision-making can result in total savings between 8-20% of laboratory costs.
North America accounted for the highest share of 28.57% in the global lateral flow assays market in 2022. The region is dominating among all the regions due to several factors, such as the increase in the prevalence of infectious diseases such as COVID-19, influenza, HIV, chronic conditions & lifestyle diseases, easy availability, and the high affordability of technologically advanced LFAs, presence of key vendor for the LFAs. Moreover, the presence of advanced healthcare infrastructure and the availability of government funding for research will likely augment the expansion of the LFA market for LFAs in this region. For instance, In July 2020, the NIH invested USD 248.7 million in developing new technologies to deal with the challenges associated with the testing of COVID-19.
Europe's lateral flow assays market was valued at USD 2.58 billion in 2022. The region has developed healthcare infrastructure with the availability of advanced lateral flow assay devices coupled with the high prevalence of infectious and chronic diseases, which has significantly contributed to the overall growth of the lateral flow assay market. Moreover, the region is affected by the increasing prevalence of infectious diseases, which include HIV, Haemophilus influenzae, Meningococcal disease, Streptococcus pneumoniae, etc., contributing to the growth of the market.
The APAC lateral flow assays market is expected to register the fastest growth rate in the global market at a CAGR of 3.90% during the forecast period. Developing countries comprise 84% of the world's population, and Asia accounts for about 60%, making it one of the significant contributors. The incidence of communicable and non-communicable diseases such as diabetes, obesity, cardiovascular disease, and cancer is increasing much faster in developing countries than in developed countries. About 4.3 million people die each year in developing countries from acute respiratory infections, 1 million from malaria, and about 5 million from AIDS and tuberculosis. In 2013, about 8 million people in these countries died from non-communicable diseases before her 60th birthday. Developing countries continue to struggle to meet the challenges of diseases that are preventable and treatable in developed countries.
The global lateral flow assay market is highly dynamic, with several global and local players offering various instruments/analyzers and reagents for diagnosing various clinical testing, food safety, Veterinary Diagnostics, drug testing, etc. The industry is consolidated with global players accounting for dominant shares. Abbott, Danaher, F. Hoffmann-La Roche, Quidel, and Siemens Healthineers are the leading players and account for significant global lateral flow assays market share.
Global players focus on developing technologically advanced diagnoses and enlarging their product portfolio to remain competitive. The companies are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers such as Abbott, F. Hoffmann-La Roche, Danaher, Quidel, and Siemens Healthineers are continuously focusing on product development and offering diagnostics with new technology to increase their market presence. Merck, a leading science and technology company, has broken ground today at its first US lateral flow membrane manufacturing facility in Sheboygan, Wisconsin. Lateral flow membranes are a key component of rapid diagnostic test kits for various applications, including Covid-19 testing. The new facility is backed by his USD 128 million contract award from the US Department of Defense (DoD) on behalf of the US Department of Health and Human Services.
Frequently Asked Questions
How big is the lateral flow assays market?
The global lateral flow assays market size was valued at USD 9.53 billion in 2022 and is expected to reach USD 11.30 billion by 2028.
What is the growth rate of the lateral flow assays market?
The global lateral flow assays market share is growing at a CAGR of 2.89% from 2022-2028.
Which are the key companies in the global lateral flow assays market?
Abbott, F. Hoffmann-La Roche, Danaher, Siemens Healthineers, and Danaher are the key vendors in the global lateral flow assays market.
Which region holds the most significant global lateral flow assays market share?
North America dominates the global lateral flow assays market with a 28.57% share.
What are the rising trends in the lateral flow assay market?
Smartphone and AI integration in lateral flow immunoassay, evolving new applications of lateral flow assays, and a surge in demand for lateral flow assays in the food & beverage industry are the growing trends in the global lateral flow assays market.
The lateral flow assays market is expected to grow at a CAGR of approximately 2.89% from 2022 to 2028.
The following factors are likely to contribute to the growth of the global lateral flow assays market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the lateral flow assays market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation by Product
Segmentation by Application
Segmentation by Technique
Segmentation by End-Users
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 MARKET OVERVIEW
6.1.1 MARKET DYNAMICS
6.1.2 MARKET SEGMENTATION
6.1.3 VENDOR ANALYSIS
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 SMARTPHONE & ARTIFICIAL INTELLIGENCE INTEGRATION IN LATERAL FLOW IMMUNOASSAY
9.2 NEW APPLICATIONS OF LFAS
9.3 SURGE IN DEMAND FOR LFAS IN FOOD & BEVERAGE INDUSTRY
10 MARKET GROWTH ENABLERS
10.1 PREVALENCE OF CHRONIC & INFECTIOUS DISEASES
10.2 ADOPTION OF HOME-BASED LFA DEVICES
10.3 DEMAND FOR POC TESTING
11 MARKET RESTRAINTS
11.1 AVAILABILITY OF ALTERNATIVE TESTING APPROACHES
11.2 INCONSISTENT RESULTS & LIMITATIONS OF LFA TESTS
11.3 CHALLENGES IN RAW MATERIAL SOURCING & LFA DEVELOPMENT
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHT BY GEOGRAPHY SEGMENTATION
12.2.2 INSIGHT BY PRODUCT SEGMENTATION
12.2.3 INSIGHT BY TECHNIQUE SEGMENTATION
12.2.4 INSIGHT BY APPLICATION SEGMENTATION
12.2.5 INSIGHT BY END-USER SEGMENTATION
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 KITS & REAGENTS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 READERS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 CLINICAL DIAGNOSTICS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 FOOD SAFETY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 VETERINARY DIAGNOSTICS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
15 TECHNIQUE
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 SANDWICH ASSAYS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 COMPETITIVE ASSAYS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS & CLINICS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOME HEALTHCARE
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 DIAGNOSTIC LABORATORIES
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 FOOD & BEVERAGE COMPANIES
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY
16.7 PHARMA & BIOTECH COMPANIES
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
16.7.3 MARKET BY GEOGRAPHY
16.8 OTHERS
16.8.1 MARKET OVERVIEW
16.8.2 MARKET SIZE & FORECAST
16.8.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NORTH AMERICA: PRODUCT SEGMENTATION
18.4 NORTH AMERICA: APPLICATION SEGMENTATION
18.5 NORTH AMERICA: TECHNIQUE SEGMENTATION
18.6 NORTH AMERICA: END-USER SEGMENTATION
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 EUROPE: PRODUCT SEGMENTATION
19.4 EUROPE: APPLICATION SEGMENTATION
19.5 EUROPE: TECHNIQUE SEGMENTATION
19.6 EUROPE: END-USER SEGMENTATION
19.7 KEY COUNTRIES
19.7.1 UK: MARKET SIZE & FORECAST
19.7.2 FRANCE: MARKET SIZE & FORECAST
19.7.3 GERMANY: MARKET SIZE & FORECAST
19.7.4 ITALY: MARKET SIZE & FORECAST
19.7.5 RUSSIA: MARKET SIZE & FORECAST
19.7.6 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 APAC: PRODUCT SEGMENTATION
20.4 APAC: APPLICATION SEGMENTATION
20.5 APAC: TECHNIQUE SEGMENTATION
20.6 APAC: END-USER SEGMENTATION
20.7 KEY COUNTRIES
20.7.1 INDIA: MARKET SIZE & FORECAST
20.7.2 CHINA: MARKET SIZE & FORECAST
20.7.3 JAPAN: MARKET SIZE & FORECAST
20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
20.7.6 PHILIPPINES: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 LATIN AMERICA: PRODUCT SEGMENTATION
21.4 LATIN AMERICA: APPLICATION SEGMENTATION
21.5 LATIN AMERICA: TECHNIQUE SEGMENTATION
21.6 LATIN AMERICA: END-USER SEGMENTATION
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
22.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
22.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION
22.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
24 KEY COMPANY PROFILES
24.1 ABBOTT
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 F. HOFFMANN-LA ROCHE
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 SIEMENS HEALTHINEERS
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 THERMO FISHER SCIENTIFIC
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 QUIDEL
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ABAXIS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ABINGDON HEALTH
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 ACCESS BIO
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 ARBOR VITA
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 ASSURE TECH
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 ATOMO DIAGNOSTICS
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 ACCUBIOTECH
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 BD
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 BIOMÉRIEUX
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.1 BIOLYTICAL LABORATORIES
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 BIO-RAD LABORATORIES
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 BIOSYNEX
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 CUPID
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 DIALAB
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 INTEC
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 J. MITRA & CO. PVT.LTD.
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 KHB
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 MERIL LIFE SCIENCES
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 MERCK KGAA
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 MP BIOMEDICALS
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 MEDSOURCE OZONE BIOMEDICALS
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 NANJING SYNTHGENE MEDICAL TECHNOLOGY
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 ORASURE TECHNOLOGIES
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 PERKINELMER
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 PREMIER MEDICAL
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS
25.27 QIAGEN
25.27.1 BUSINESS OVERVIEW
25.27.2 PRODUCT OFFERINGS
25.28 REGA BIOTECHNOLOGY
25.28.1 BUSINESS OVERVIEW
25.28.2 PRODUCT OFFERINGS
25.29 SD BIOSENSOR
25.29.1 BUSINESS OVERVIEW
25.29.2 PRODUCT OFFERINGS
25.30 TÜRKLAB A.S.
25.30.1 BUSINESS OVERVIEW
25.30.2 PRODUCT OFFERINGS
25.31 TRINITY BIOTECH
25.31.1 BUSINESS OVERVIEW
25.31.2 PRODUCT OFFERINGS
25.32 WONDFO
25.32.1 BUSINESS OVERVIEW
25.32.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY PRODUCT
27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
27.1.2 EUROPE: PRODUCT SEGMENTATION
27.1.3 APAC: PRODUCT SEGMENTATION
27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
27.2 MARKET BY TECHNIQUE
27.2.1 NORTH AMERICA: TECHNIQUE SEGMENTATION
27.2.2 EUROPE: TECHNIQUE SEGMENTATION
27.2.3 APAC: TECHNIQUE SEGMENTATION
27.2.4 LATIN AMERICA: TECHNIQUE SEGMENTATION
27.2.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION
27.3 MARKET BY APPLICATION
27.3.1 NORTH AMERICA: APPLICATION SEGMENTATION
27.3.2 EUROPE: APPLICATION SEGMENTATION
27.3.3 APAC: APPLICATION SEGMENTATION
27.3.4 LATIN AMERICA: APPLICATION SEGMENTATION
27.3.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
27.4 MARKET BY END-USER
27.4.1 NORTH AMERICA: END-USER SEGMENTATION
27.4.2 EUROPE: END-USER SEGMENTATION
27.4.3 APAC: END-USER SEGMENTATION
27.4.4 LATIN AMERICA: END-USER SEGMENTATION
27.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
27.5 MARKET BY GEOGRAPHY
27.5.1 KITS & REAGENTS: GEOGRAPHY SEGMENTATION
27.5.2 READERS: GEOGRAPHY SEGMENTATION
27.5.3 CLINICAL DIAGNOSTICS: GEOGRAPHY SEGMENTATION
27.5.4 FOOD SAFETY: GEOGRAPHY SEGMENTATION
27.5.5 VETERINARY DIAGNOSTICS: GEOGRAPHY SEGMENTATION
27.5.6 OTHERS: GEOGRAPHY SEGMENTATION
27.5.7 SANDWICH ASSAYS: GEOGRAPHY SEGMENTATION
27.5.8 COMPETITIVE ASSAYS: GEOGRAPHY SEGMENTATION
27.5.9 HOSPITALS & CLINICS: GEOGRAPHY SEGMENTATION
27.5.10 HOME HEALTHCARE: GEOGRAPHY SEGMENTATION
27.5.11 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION
27.5.12 FOOD & BEVERAGE COMPANIES: GEOGRAPHY SEGMENTATION
27.5.13 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
27.5.14 OTHERS: GEOGRAPHY SEGMENTATION
28 APPENDIX
28.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL LATERAL FLOW ASSAY MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 GLOBAL LATERAL FLOW ASSAY MARKET: 2022 & 2028 ($ BILLION)
EXHIBIT 4 GLOBAL LATERAL FLOW ASSAY MARKET: SEGMENTATION
EXHIBIT 5 IMPACT OF SMARTPHONE & ARTIFICIAL INTELLIGENCE INTEGRATION IN LATERAL FLOW IMMUNOASSAY
EXHIBIT 6 IMPACT OF NEW APPLICATIONS OF LFAS
EXHIBIT 7 IMPACT OF SURGE IN DEMAND FOR LFAS IN FOOD & BEVERAGE INDUSTRY
EXHIBIT 8 ADVANTAGES OF LFA TESTS IN FOOD & BEVERAGE INDUSTRY
EXHIBIT 9 IMPACT OF PREVALENCE OF CHRONIC & INFECTIOUS DISEASES
EXHIBIT 10 GLOBAL INFECTIOUS DISEASE STATISTICS
EXHIBIT 11 IMPACT OF ADOPTION OF HOME-BASED LFA DEVICES
EXHIBIT 12 IMPACT OF DEMAND FOR POC TESTING
EXHIBIT 13 ADVANTAGES OF RAPID/POC TESTS
EXHIBIT 14 IMPACT OF AVAILABILITY OF ALTERNATIVE TESTING APPROACHES
EXHIBIT 15 ALTERNATIVE APPROACHES TO LATERAL FLOW TESTING
EXHIBIT 16 IMPACT OF INCONSISTENT RESULTS & LIMITATIONS OF LFA TESTS
EXHIBIT 17 LIMITATIONS OF LFA TESTS
EXHIBIT 18 IMPACT OF CHALLENGES IN RAW MATERIAL SOURCING & LFA DEVELOPMENT
EXHIBIT 19 GLOBAL LATERAL FLOW ASSAY MARKET 2022–2028 ($ BILLION)
EXHIBIT 20 GLOBAL LATERAL FLOW ASSAY MARKET BY GEOGRAPHY
EXHIBIT 21 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT
EXHIBIT 22 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE
EXHIBIT 23 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION
EXHIBIT 24 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER
EXHIBIT 25 FIVE FORCES ANALYSIS 2022
EXHIBIT 26 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)
EXHIBIT 27 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT
EXHIBIT 28 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 29 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 ($ BILLION)
EXHIBIT 31 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 ($ BILLION)
EXHIBIT 33 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 34 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION
EXHIBIT 35 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 36 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS 2022–2028 ($ BILLION)
EXHIBIT 39 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 ($ BILLION)
EXHIBIT 41 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 ($ BILLION)
EXHIBIT 43 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)
EXHIBIT 45 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)
EXHIBIT 46 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE
EXHIBIT 47 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE: INCREMENTAL GROWTH
EXHIBIT 48 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE: ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 ($ BILLION)
EXHIBIT 51 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 ($ BILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 54 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER
EXHIBIT 55 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 56 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 ($ BILLION)
EXHIBIT 59 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 ($ BILLION)
EXHIBIT 61 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 ($ BILLION)
EXHIBIT 63 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 ($ BILLION)
EXHIBIT 65 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 ($ BILLION)
EXHIBIT 67 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)
EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY (2022 & 2028)
EXHIBIT 70 LATERAL FLOW ASSAY MARKET BY GEOGRAPHY
EXHIBIT 71 LATERAL FLOW ASSAY MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 72 LATERAL FLOW ASSAY MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 73 NORTH AMERICA LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)
EXHIBIT 74 NORTH AMERICA LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 NORTH AMERICA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 76 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)
EXHIBIT 77 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 78 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)
EXHIBIT 79 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA (2022 & 2028)
EXHIBIT 81 US INFECTIOUS DISEASE STATISTICS
EXHIBIT 82 US LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 83 CANADA INFECTIOUS DISEASE STATISTICS
EXHIBIT 84 CANADA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 85 EUROPE LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)
EXHIBIT 86 EUROPE LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 87 EUROPE LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 88 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)
EXHIBIT 89 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 90 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)
EXHIBIT 91 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 92 INCREMENTAL GROWTH IN EUROPE (2022 & 2028)
EXHIBIT 93 UK LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 94 FRANCE LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 95 GERMANY LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 96 ITALY LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 97 RUSSIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 98 SPAIN LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 99 APAC LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)
EXHIBIT 100 APAC LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 101 APAC LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 102 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)
EXHIBIT 103 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 104 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)
EXHIBIT 105 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 106 INCREMENTAL GROWTH IN APAC (2022 & 2028)
EXHIBIT 107 INDIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 108 CHINA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 109 JAPAN LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 110 SOUTH KOREA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 111 AUSTRALIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 112 PHILIPPINES LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 113 LATIN AMERICA LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)
EXHIBIT 114 LATIN AMERICA LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 115 LATIN AMERICA LATERAL FLOW ASSAY MARKET 2022–2028 ($ BILLION)
EXHIBIT 116 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)
EXHIBIT 117 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 118 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)
EXHIBIT 119 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 120 INCREMENTAL GROWTH IN LATIN AMERICA (2022 & 2028)
EXHIBIT 121 BRAZIL LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 122 MEXICO LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 123 ARGENTINA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 124 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)
EXHIBIT 125 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 126 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET 2022–2028 ($ BILLION)
EXHIBIT 127 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)
EXHIBIT 128 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)
EXHIBIT 129 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)
EXHIBIT 130 INCREMENTAL GROWTH BY END-USER (2022 & 2028)
EXHIBIT 131 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2022 & 2028)
EXHIBIT 132 TURKEY LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 133 SAUDI ARABIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 134 SOUTH AFRICA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)
EXHIBIT 135 GLOBAL LATERAL FLOW ASSAY MARKET: TECHNOLOGY EXPERTISE
EXHIBIT 136 GLOBAL LATERAL FLOW ASSAY MARKET: DOMINANCE ANALYSIS
EXHIBIT 137 ABBOTT: TOTAL ANNUAL REVENUE, 2019–2021 ($ BILLION)
EXHIBIT 138 ABBOTT: REVENUE SHARE BY DIAGNOSTICS SEGMENT, 2021 (%)
EXHIBIT 139 F. HOFFMANN-LA ROCHE: TOTAL ANNUAL REVENUE, 2019–2021 ($ BILLION)
EXHIBIT 140 THERMO FISHER SCIENTIFIC REVENUE, 2019–2021 ($ BILLION)
EXHIBIT 141 THERMO FISHER SCIENTIFIC REVENUE BY BUSINESS SEGMENTS, 2019–2021 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2022
TABLE 3 AI-BASED LFA DEVICES
TABLE 4 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 ($ BILLION)
TABLE 5 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 (%)
TABLE 6 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 ($ BILLION)
TABLE 7 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 (%)
TABLE 8 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 ($ BILLION)
TABLE 9 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 (%)
TABLE 10 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 ($ BILLION)
TABLE 11 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 (%)
TABLE 12 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 ($ BILLION)
TABLE 13 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 (%)
TABLE 14 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)
TABLE 15 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)
TABLE 16 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 ($ BILLION)
TABLE 17 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 (%)
TABLE 18 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 ($ BILLION)
TABLE 19 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 (%)
TABLE 20 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 ($ BILLION)
TABLE 21 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 (%)
TABLE 22 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 ($ BILLION)
TABLE 23 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 (%)
TABLE 24 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 ($ BILLION)
TABLE 25 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 (%)
TABLE 26 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 ($ BILLION)
TABLE 27 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 (%)
TABLE 28 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 ($ BILLION)
TABLE 29 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 (%)
TABLE 30 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)
TABLE 31 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)
TABLE 32 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 33 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 34 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 35 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 36 QUIDEL: MAJOR PRODUCT OFFERINGS
TABLE 37 ABAXIS: MAJOR PRODUCT OFFERINGS
TABLE 38 ABINGDON HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 39 ABINGDON HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 40 ARBOR VITA: MAJOR PRODUCT OFFERINGS
TABLE 41 ASSURE TECH: MAJOR PRODUCT OFFERINGS
TABLE 42 ATOMO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 43 ACCUBIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 44 BD: MAJOR PRODUCT OFFERINGS
TABLE 45 BIOMÉRIEUX: MAJOR PRODUCT OFFERINGS
TABLE 46 BIOLYTICAL LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 47 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 48 BIOSYNEX: MAJOR PRODUCT OFFERINGS
TABLE 49 CUPID: MAJOR PRODUCT OFFERINGS
TABLE 50 DIALAB: MAJOR PRODUCT OFFERINGS
TABLE 51 HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH: MAJOR PRODUCT OFFERINGS
TABLE 52 INTEC: MAJOR PRODUCT OFFERINGS
TABLE 53 J. MITRA & CO. PVT. LTD.: MAJOR PRODUCT OFFERINGS
TABLE 54 KHB: MAJOR PRODUCT OFFERINGS
TABLE 55 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 56 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 57 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS
TABLE 58 MEDSOURCE OZONE BIOMEDICALS: MAJOR PRODUCT OFFERINGS
TABLE 59 NANJING SYNTHGENE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 60 ORASURE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 61 PERKINELMER: MAJOR PRODUCT OFFERINGS
TABLE 62 PREMIER MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 63 QIAGEN: MAJOR PRODUCT OFFERINGS
TABLE 64 REGA BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 65 SD BIOSENSOR: MAJOR PRODUCT OFFERINGS
TABLE 66 TÜRKLAB A. S: MAJOR PRODUCT OFFERINGS
TABLE 67 TRINITY BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 68 WONDFO: MAJOR PRODUCT OFFERINGS
TABLE 69 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)
TABLE 70 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)
TABLE 71 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)
TABLE 72 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)
TABLE 73 EUROPE LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)
TABLE 74 EUROPE LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)
TABLE 75 APAC LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)
TABLE 76 APAC LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)
TABLE 77 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)
TABLE 78 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)
TABLE 79 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)
TABLE 80 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)
TABLE 81 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)
TABLE 82 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)
TABLE 83 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)
TABLE 84 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)
TABLE 85 EUROPE LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)
TABLE 86 EUROPE LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)
TABLE 87 APAC LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)
TABLE 88 APAC LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)
TABLE 89 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)
TABLE 90 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)
TABLE 91 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)
TABLE 92 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)
TABLE 93 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)
TABLE 94 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)
TABLE 95 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)
TABLE 96 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)
TABLE 97 EUROPE LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)
TABLE 98 EUROPE LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)
TABLE 99 APAC LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)
TABLE 100 APAC LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)
TABLE 101 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)
TABLE 102 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)
TABLE 103 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)
TABLE 104 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)
TABLE 105 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)
TABLE 106 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)
TABLE 107 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)
TABLE 108 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)
TABLE 109 EUROPE LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)
TABLE 110 EUROPE LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)
TABLE 111 APAC LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)
TABLE 112 APAC LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)
TABLE 113 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)
TABLE 114 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)
TABLE 115 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)
TABLE 116 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)
TABLE 117 GLOBAL LATERAL FLOW ASSAY MARKET BY GEOGRAPHY, 2022–2028 ($ BILLION)
TABLE 118 GLOBAL LATERAL FLOW ASSAY MARKET BY GEOGRAPHY, 2022–2028 (%)
TABLE 119 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 ($ BILLION)
TABLE 120 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 (%)
TABLE 121 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 ($ BILLION)
TABLE 122 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 (%)
TABLE 123 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 ($ BILLION)
TABLE 124 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 (%)
TABLE 125 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 ($ BILLION)
TABLE 126 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 (%)
TABLE 127 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 ($ BILLION)
TABLE 128 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 (%)
TABLE 129 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)
TABLE 130 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)
TABLE 131 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 ($ BILLION)
TABLE 132 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 (%)
TABLE 133 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 ($ BILLION)
TABLE 134 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 (%)
TABLE 135 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 ($ BILLION)
TABLE 136 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 (%)
TABLE 137 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 ($ BILLION)
TABLE 138 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 (%)
TABLE 139 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 ($ BILLION)
TABLE 140 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 (%)
TABLE 141 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 ($ BILLION)
TABLE 142 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 (%)
TABLE 143 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 ($ BILLION)
TABLE 144 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 (%)
TABLE 145 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)
TABLE 146 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
